Paul Whiteley/ LinkedIn
Jun 24, 2026, 17:36
Paul Whiteley: Neurodevelopmental and Autism Risks in Fetal and Neonatal Alloimmune Thrombocytopenia
Paul Whiteley, Autism Researcher, shared a post on X about a recent article by Abdelaziz Hendy et al. published in Evidence-Based Nursing, adding:
” ‘All children with fetal neonatal alloimmune thrombocytopenia should have long-term structured neurodevelopmental and autism screening even if they do not have an intracranial haemorrhage (ICH)‘
Another one of the autisms.
And following an immune disorder.”
Title: Are higher autism rates in FNAIT without intracranial haemorrhage real or a result of increased screening?
Authors: Abdelaziz Hendy, Abdulqadir J Nashwan
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 17:22Kavitha Dev: A Low Platelet Count Isn’t Always Critical, But It Should Never Be Ignored
-
Jun 24, 2026, 17:04Recurrent Cervical Internal Carotid Vasospasm Linked to Autosomal Recessive PTGIS Defect – International Journal of Stroke
-
Jun 24, 2026, 16:49Gaurav Kharya: Bridging the Gap in Safe Blood Access for Patients Who Can’t Wait
-
Jun 24, 2026, 16:40William Wallace: Vitamin C and Collagen Work as One Biological System
-
Jun 24, 2026, 16:32Arlindo Nascimento de Lemos Junior: Thrombus Echogenicity as a Predictor of Post-Thrombotic Syndrome Severity After DVT
-
Jun 24, 2026, 16:09Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration
-
Jun 24, 2026, 16:03Von Willebrand Disease as a Common Yet Under-Recognised Bleeding Disorder – EHC
-
Jun 24, 2026, 15:57Maia Meier: Women with Bleeding Disorders Reach the Summit of Mont Blanc
-
Jun 24, 2026, 15:40Annette Bowyer: The Emerging Role of Extravascular Factor VII in Haemostasis